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Abstract. Molecular data are required to improve our understanding of the epidemiology of leptospirosis in Africa and
to identify sources of human infection. We applied molecular methods to identify the infecting Leptospira species and
genotypes among patients hospitalized with fever in Tanzania and compared these with Leptospira genotypes detected
among animals in Tanzania to infer potential sources of human infection.Weperformed lipL32 real-timePCR todetect the
presence of pathogenic Leptospira in acute-phase plasma, serum, and urine samples obtained from study participants
with serologically confirmed leptospirosis and participants who had diedwith febrile illness. Leptospira blood culture was
also performed. In positive specimens, we performed species-specific PCR and compared participant Leptospira secY
sequences with Leptospira reference sequences and sequences previously obtained from animals in Tanzania. We
detected Leptospira DNA in four (3.6%) of 111 participant blood samples. We detected Leptospira borgpetersenii (one
participant, 25.0%), Leptospira interrogans (one participant, 25.0%), and Leptospira kirschneri (one participant, 25.0%)
(one [25%] undetermined). Phylogenetic comparison of secY sequence from the L. borgpetersenii and L. kirschneri
genotypes detected from participants was closely related to but distinct from genotypes detected among local livestock
species. Our results indicate that a diverse range of Leptospira species is causing human infection. Although our analysis
suggests a close relationship between Leptospira genotypes found in people and livestock, continued efforts are needed
to obtain more Leptospira genetic material from human leptospirosis cases to help prioritize Leptospira species and
genotypes for control.
INTRODUCTION
Leptospirosis is a zoonotic disease, with an estimated an-
nual incidence of up to approximately 100 cases per 100,000
people in Tanzania.1 Previous studies in Tanzania have iden-
tified contact with cattle and working in rice fields as risk
factors for acute human leptospirosis,2,3 but further data are
needed to understand transmission pathways and to confirm
sources of Leptospira infection for people. Pathogenic Lep-
tospira have been detected by culture or nucleic acid ampli-
fication methods in a number of animal hosts in Tanzania
including cattle, goats, sheep, and rodents.4,5 Sequence-
based species identification of Tanzanian animal isolates and
DNA indicates that Leptospira borgpetersenii, Leptospira
interrogans, and Leptospira kirschneri are circulating in animal
populations in Tanzania. However, the contributions, and
relative importance, of these Leptospira species to human
disease in Tanzania are unclear.
Direct detection of Leptospira by culture can be challenging
in humans as Leptospira are fastidious organisms that may
take weeks to grow in culture, limiting the utility of this ap-
proach to provide a timely diagnosis for an acutely unwell
patient.6 Because of the challenges of Leptospira culture
in vitro, molecular diagnostic assays based on nucleic acid
amplification tests (NAAT) including real-time PCR of the
lipL32 gene have been developed to aid diagnosis. PCR
techniques have also been used to directly determine the
species of infecting Leptospira for some of the more common
pathogenic Leptospira species. This has been achieved using
PCR-based amplification of secY and ompL1 genes using
species-specific primers and probes to show variation be-
tweenLeptospira species.7 The sensitivity of these assays has
not been fully determined but when used in a two-step algo-
rithm with a lipL32 assay was able to identify four common
pathogenic Leptospira species (L. borgpetersenii, L. interrogans,
L. kirschneri, and Leptospira noguchii).7 Sequence-based typing
schemes of selected gene targets (e.g., 16S rRNA rrs, secY, and
lfb1)8–10 have also been developed for Leptospira. Amplification
of a∼435-bp fragment of the secYgenehasbeen shown to have
good phylogenetic discrimination between pathogenic Lep-
tospira species and has been widely used in the East African
region.4,8,11 Sequence-based approaches have not only been
applied to Leptospira isolates8 but can also be applied directly to
clinical samples todetermine the infectingspeciesandgenotype,
and to investigate links between human and animal Leptospira
infection.12
In this study, we aimed to characterize the genetic diversity
of humanLeptospira infection in northernTanzania and to infer
possible sources of human infection. We applied direct
pathogen detection methods including culture and NAAT to
detect Leptospira infection and determine the infecting Lep-
tospira species among febrile patients in northern Tanzania.
We then used sequence-based analysis of the secY gene to
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compare pathogenic Leptospira genotypes detected in pa-
tients with those previously reported in animals in Tanzania to
advance our understanding of the relationship between hu-
man and animal Leptospira infection.
METHODS
Study setting. Our study was performed among patients
presenting to the Kilimanjaro Christian Medical Centre
(KCMC), a 450-bed zonal referral hospital, and to Mawenzi
Regional Referral Hospital (MRRH), a 300-bed regional referral
hospital. Both hospitals are located in the Moshi municipal
district in northern Tanzania. Moshi (population ∼180,000) is
the administrative capital of the Kilimanjaro Region (pop-
ulation ∼1.6 million), which is located in the north of Tanzania.
Study procedures and participants. To detect the pres-
ence of Leptospira among febrile patients, we used plasma,
serum, and urine collected from patients enrolled in two fever
etiology studies that have been previously described.2,13
Briefly, we enrolled adult and pediatric inpatients admitted
with a fever at the KCMC and MRRH from September 2007
through August 2008 (study 1) and from February 2012
throughMay2014 (study2). Aquestionnairewasadministered
to each participant that included questions on the duration of
illness and any antibacterial treatment received before pre-
sentation at the hospital. We used participant questionnaire
responses to estimate the duration of their fever (median and
range) before sample collection.
Study personnel drew blood from each participant for se-
rology, and participants were asked to return 4–6 weeks after
enrollment for collection of a convalescent serum sample
(both studies). We also collected acute urine samples from
participants in study 1 and acute blood samples for Leptospira
culture from participants enrolled in study 2.
Leptospira culture. For Leptospira culture, three drops
of whole blood were inoculated immediately into 6-mL
Ellinghausen–McCullough–Johnson–Harris culture media
supplemented with 5-fluorouracil. Inoculated culture media
were batch-shipped to the U.S. CDC where they were kept at
30C for up to 6 months and monitored weekly for Leptospira
growth by darkfield microscopic examination.
Selection of participants for real-time PCR.We selected
participants for real-time PCR testing based on predeter-
mined serological case definitions. In both studies, micro-
scopic agglutination testing (MAT) was performed on acute
and convalescent serum samples using a panel of 20 serovars
belonging to 17 serogroups following standard laboratory
procedures as previously described (Supplemental Table).13–15
Participantswhohadeither a³ 4-fold rise inMAT titersbetween
acute and convalescent serum samples or a single reciprocal
MAT titer ³ 800 to any serovar on acute or convalescent Lep-
tospira were considered to be positive for acute leptospirosis
and were selected for real-time PCR.16 The predominant re-
active serogroup for each was defined as the serogroup con-
taining the serovar with the highest agglutinating titer. In
addition, we also selected study participants who had died
before study follow-up for inclusion in our study (subsequently
referred to as decedent participants). Such participants had
provided only an acute-phase serologic sample, and asMAT is
considered insensitive during the acute phase of illness, we
included these samples to allow for missed cases within the
decedent participant group.17
Molecular detection of Leptospira DNA. We performed
real-time PCR testing to detect pathogenic LeptospiraDNA in
archived acute plasma and urine samples for participants
recruited from study 1, and in acute serum samples for par-
ticipants recruited from study 2. First, we extracted DNA from
plasma and serum using the QIAamp® DNA Blood Mini Kit
(Qiagen, Hilden, Germany) according to the manufacturer’s
instructions with a final elution volume of 100 μL to increase
DNA concentration. DNA was extracted from urine using
QIAamp DNA Blood Mini Kit with a pretreatment step
designed to maximize the yield of bacterial DNA from bi-
ological samples.18–20 Briefly, up to 1,000 μL of urine was
centrifuged at 10,000 × g for 10 minutes. The resulting pellet
was washed in 200 μL Tris-EDTA (TE) buffer (Biotechnology
grade, pH 8.0; VWR International Ltd., Lutterworth, United
Kingdom) and then resuspended in an enzymemix containing
50μL lysozyme (10mg/mL), 50μLmutanolysin (1mg/mL), and
4μL lysostaphin (1mg/mL)madeup to a final volumeof 200μL
with TE buffer, and incubated at 37C for 1 hour. Sub-
sequently, 180 μL lysis buffer (Buffer AL, Qiagen) and 20 μL
proteinase K were added to each sample, and extraction was
completed following the standard spin column extraction
protocol.
To detect pathogenic Leptospira DNA in participant sam-
ples, we used a real-time PCR assay targeting the lipL32 gene
following previously published protocols,21,22 using the ABI
7500 real-time PCR system (Thermo Fisher Scientific, Wal-
tham, MA). Assays were performed at National Collaborating
Centre for Reference and Research on Leptospirosis, Dutch
Royal Tropical Institute (now Amsterdam Medical Centre),
Amsterdam, the Netherlands (Study 1), and at the Bacterial
Special Pathogens Laboratory, U.S. CDC, Atlanta, GA (study
2). Primers and probes are shown in Table 1. Inhibition was
evaluated using an endogenous internal positive control (hu-
man rnaseP) (study 1) or an exogenous positive control
(Applied Biosystems). Each real-time reaction run included
DNA extracted from a pure culture of L. interrogans as a
positive control (study 1: L. interrogans serovar Copenhagenii
strain Wijnberg supplied by the National Leptospirosis
Reference Laboratory, Amsterdam, the Netherlands; study 2:
L. interrogans serovar Icterohaemorrhagiae strain RGA from
the American Type Culture Collection [ATCC] number
43642).24 In study 1, the master mix contained (per reaction)
1.25 μL of each primer, used at a concentration of 10 μM;
0.25 μL probe (10 μM concentration); 0.5 μL of ROX (1:10
dilution); 4.25 μL nuclease-free water; 12.5 μL Platinum
quantitative PCR (qPCR) Supermix-UDG (Thermo Fisher
Scientific, Waltham, MA); and 5 μL of the sample. Inhibition
was evaluated in a separate qPCR reaction run on the same
plate. Themaster mix for this reaction contained (per reaction)
1μLof eachprimer (10μMconcentration), 0.3μLprobe (10μM
concentration), 0.5 μL ROX (1:10 dilution), 4.7 μL nuclease-
free water, 12.5 μL Platinum qPCR Supermix-UDG (Thermo
Fisher Scientific), and 5 μL of the sample. For study 2, the
master mix contained (per reaction) 0.9 μL of each primer
(20 μM concentration), 0.5 μL probe (5 μM concentration),
0.3 μL nuclease-free water, 10 μL PerfeCTa® qPCR Tough-
Mix®, Low ROX™ (Quanta Biosciences, Gaithersburg, MD),
2μL 10XExo IPCMix, 0.4μL 50XExo IPCDNA, and 5μL of the
sample. For both studies, the amplification protocol consisted
of 2 minutes at 50C and 10 minutes at 95C, followed by 45
cycles of amplification (95C for 15 seconds and 60C for 60
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seconds [study 1] or 58C for 60 seconds [study 2]). PCR-
grade water was used as a non-template, negative control,
and included in duplicate in each PCR run. Samples were
tested in duplicate. Reaction runswere considered valid when
both replicates of the L. interrogans control amplified with
cycle threshold (Ct) values < 40 and when all replicates of the
negative controls showed no evidence of amplification.
Samples with a Ct value < 40 were considered positive for
pathogenic Leptospira infection.
Identification of infecting Leptospira species and
genotype. For samples that were positive for pathogenic
LeptospiraDNA by lipL32 real-time PCR assay, we performed
real-time PCR using sets of Leptospira species–specific
probes and flanking primers designed for the direct detection
of common Leptospira species in clinical samples as shown in
Table 1. Primers and probes targeting the secY gene were
used for the detection of L. interrogans, L. kirschneri, and
Leptospira noguchi. Primers and probes targeting the ompL1
genewere used for the detection of L. borgpetersenii.7 In each
run, we included negative controls and species-specific posi-
tive controls (L. borgpetersenii strain BallumMus 127DMSO 4/
21/15; L. interrogans strain Icterohaemorrhagiae RGA, ATCC
43462; L. kirschneri serovar Cynopteri strain 3522C, ATCC
49945; and L. noguchi strain 2001034031).
For samples that were positive by lipL32 real-time PCR, we
also amplified and sequenced a∼435-base pair (bp) fragment
of the secY gene to investigate the infecting genotype within
each Leptospira species. PCR amplification was performed
using previously published protocols. PCR amplicons were
purified using the QIAquick PCR Purification Kit (Qiagen), and
Sanger sequencingwasperformed bySourceBioscience Ltd.
(Nottingham, United Kingdom).
Phylogenetic analysis of the secY gene. We performed
phylogenetic analysis of the secY gene using MEGA7.0 soft-
ware.25 Final sequences were aligned and compared
with sequences from reference serovars accessed through
GenBank8,26 and with sequences from other studies in
Tanzania4,27 using the ClustalW algorithm. Notably, included
in the comparison were sequences of Leptospira detected in
Tanzanian livestock in the Moshi municipal district during the
same time period as study 2 (2013–2014). This included 17
Leptospira sequences derived from cattle samples, one se-
quence derived from a goat sample, and one derived from a
sheep sample.4 We also included published sequences from
Leptospira reference serovars,8 and from serovars previously
isolated in Tanzania in our final alignment.27 The model test
function in MEGA7.0 was used to select the most appropriate
nucleotide substitution model for the aligned sequences. The
final phylogenetic tree was generated using a maximum like-
lihood method with 500 bootstraps repeats as a test of rela-
tionships between the aligned sequences.
Research ethics. This studywas conducted in accordance
with the World Medical Association Declaration of Helsinki. It
was approved by the KCMC Research Ethics Committee
(#295), the Tanzania National Institutes for Medical Research
National EthicsCoordinatingCommittee (NIMR/HQ/R.8cNo1.
11/283 and NIMR/HQ/R.8a/Vol.IX/1499), Duke Health In-
stitutional Review Board (IRB#Pro00016134), the University of
Otago Human Ethics Committee (Health) (H15/055), and the
University of Glasgow College of Medical, Veterinary, and Life
Sciences Ethics Committee (Project No. 200120020). Written
informed consent was obtained from all participants. Study data
are available at http://dx.doi.org/10.5525/gla.researchdata.881.
RESULTS
In total, 1,849 participants who were recruited into the two
fever etiology studies had blood drawn for leptospirosis se-
rology, and 1,294 (70.0%) had Leptospira blood culture. MAT
serological testing for leptospirosis was performed on paired
acute and convalescent samples for 1,225 (66.3%) partici-
pants, and there were 108 decedents. A total of 109 (5.9%)
TABLE 1
Real-time PCR methods used to target genes of pathogenic Leptospira spp. among patients hospitalized with fever, Tanzania, 2007–2008 and
2012–2014
Genus/species Target gene Primer/probe name Sequence (59-39) Annealing temp (C) Cycles
Pathogenic Leptospira spp. lipL3222 LipL32-45F AAG CAT TAC CGC TTG TGG TG 60 40
LipL32-286R GAA CTC CCA TTT CAG CGA TT
LipL32-189P FAM-AA AGC CAG GAC AAG CGC
CG-BHQ1
Leptospira borgpetersenii ompL17 F_bpn GAT TCG GGT TAC AAT TAG ACC 65 45
R_bpn1 TTG ATC TAA CCG GAC CAT AGT
Leptospira interrogans secY7 PFLint2 CTT GAG-CCT GCG CGT TAY C 63 45
PRLint2 CCG ATA ATT CCA GCG AAG ATC
TaqLint2 TET-CTC ATT TGG TTA GGA GAA CAG
ATC A-BHQ1
Leptospira kirschneri secY7 F_nery CTG GCT TAA TCA ATG CTT CTG 60 45
R_nery CTC TTT CGG TGA TCT GTT CC
TqM_nery Texas Red-CAG TTC CAG TTG TAA TAG
ATA AGA TTC-BHQ2
Leptospira noguchii secY7 FLnog2 TCA GGG TGT AAG AAA GGT TC 63 45
RLnog2 CAA AAT TAA AGA AGA AGC AAA GAT
TaqLnog FAM-CGA TTG GCT TTT TGC TTG AAC
CAT C-BHQ1
TqM_bpn Cy5.5 (Quasar 705)-TAC TAA GGA TGG
TTT GGA CGC TGC-BHQ2
Pan Leptospira spp. SecY23 SecYFd 59-ATG CCG ATC ATY TTY GCT TC-39 52C 45
secYR3 59-TTC ATGAAGCCT TCA TAA TTTCTC
A-39
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participantsmet our selection criteria for real-timePCR testing
for Leptospira and had samples available for testing. These
included samples from 81 participants who met our serologic
case definition of leptospirosis and 28 decedent participants.
Of 109 participants, 106 (98.1%) participants had blood de-
rivatives, including plasma in 58 (53.2%) and serum in 48
(44.0%) available for testing, and 30 (27.5%) had urine avail-
able for testing.
Data on fever duration and self-reported antibacterial use
were available from 108 (99.1%) participants undergoing PCR
testing. The median (range) reported duration of the fever
before sample collection was 7 (1–366) days. Of participants,
64 (58.7%) reported antibacterial use before enrollment.
Pathogenic Leptospira testing and speciation. Lep-
tospira culture was negative on all 1,294 participants. By real-
time PCR, we detected pathogenic Leptospira DNA in three
(3.7%) of 81 participants with serologically confirmed acute
leptospirosis and one (3.6%) of 28 decedent participants
(Table 2). The decedent participant did not meet our serologic
case definition of leptospirosis (low titer in the acute sample
and no convalescent sample available). All positive PCR reac-
tions were from serum samples. Of four real-time PCR-positive
samples, species-specific real-time PCR identified one (25%)
as positive for L. borgpetersenii, one (25%) L. interrogans, and
one (25%) L. kirschneri, each in a single study participant
(Table 2). In the single decedent sample (25%) that was lipL32
real-time PCR positive, we were unable to amplify DNA using
the species-specific real-time PCR reactions.
Comparison between genetic and serological results.
When compared with the MAT serological results, all three
participants with real-time PCR-positive samples met the case
definition for acute leptospirosis by virtue of a 4-fold rise inMAT
titer between the acute and convalescent samples. The pre-
dominant reactive serogroup was Sejroe for the participants
with L. interrogans and L. kirschneri infection, and was Pyro-
genes for the participant with L. borgpetersenii infection
(Table 2). For the real-timePCR-positive decedent, a single titer
of 1:400 against serogroup Pyrogenes was obtained by MAT.
Leptospira phylogenetic analysis. SecY sequences were
obtained from two (50.0%) of four participantswhose samples
were positive by lipL32 real-time PCR. Comparison with
published secY reference sequences8 confirmed the infecting
Leptospira species as L. borgpetersenii and L. kirschneri
(Figure 1, Table 2). When compared with reference serovars,
L. borgpetersenii secY sequence from a participant in our
study was 100% identical to reference sequences from
L. borgpetersenii serovar Balcanica (EU357986), Moldaviae
(EU358070), Tarassovi (EU358057), and Tunis (EU358064).
L. kirschneri secY sequence generated in our studywas 100%
identical to sequences obtained from reference serovars in-
cluding L. kirschneri serovar Galtoni (EU358025), and serovar
Kabura (EU 357979).
Sequences obtained from participants in our study showed
not only a high degree of similarity but also some minor dis-
tinctions when compared with Leptospira secY sequences
obtained from animals in Tanzania (Figure 1).4,27 Leptospira
borgpetersenii sequences were highly similar (99.8% of
434 bp) to sequences of L. borgpetersenii serovar Hardjo
(Hardjo-bovis) isolated from cattle in the Moshi municipal
district, but with a single nucleotide substitution in the human-
derived sequence. L. kirschneri sequences were also highly
similar (99.1% of 434 bp) but differed by four nucleotide
substitutions from genotypes detected in cattle, sheep, and
goats sampled in the Moshi municipal district.
DISCUSSION
We detected LeptospiraDNA in four participants with acute
febrile illness in northern Tanzania, including one patient who
died with acute leptospirosis. Despite the small number of
real-time PCR-positive samples, our results show a striking
amount of diversity in infecting Leptospira species. Three
Leptospira species—L. borgpetersenii, L. interrogans, and
L. kirschneri—were detected in participants with acute fe-
brile illness. Sequence-based analysis showed a high de-
gree of similarity between secY sequence obtained from
L. borgpetersenii and L. kirschneri genotypes infecting people
and L. borgpetersenii and L. kirschneri genotypes detected in
local cattle, goats, and sheep also sampled in the Moshi
municipal district. The findings of our study corroborate pre-
vious serological findings that detected multiple Leptospira
types are circulating in Tanzania and support the hypothesis
that livestock are a potential source of human infection.2,4,13
To date, little information has been available regarding the
predominant Leptospira species implicated in human disease
in Tanzania.28 PerfeCTa qPCR ToughMix, Low ROX inter-
rogans, and L. kirschneri have previously been implicated as a
cause of human infection elsewhere in Tanzania although the
methods used in the earlier study lacked sufficient resolution
to discriminate to the species level.27 Our approach, which
used a combination of species-specific PCR and sequence-
based typing, has generated to our knowledge the first
TABLE 2
LipL32 and species-specific RT-PCR CT values, and MAT predominant serogroup in participants with Leptospira DNA detected, Tanzania,
2012–2014
Participant number 1 2 3 4
PCR
LipL32 CT value 38.7 36.3 32.3 38.4
L. borgpetersenii CT value ND 37.8 ND ND
Leptospira interrogans CT value 37.4 ND ND ND
L. kirschneri CT value ND ND 37.8 ND
Leptospira noguchii CT value ND ND ND ND
Leptospira species (secY sequencing) NA L. borgpetersenii L. kirschneri NA
MAT
Predominant MAT serogroup Sejroe Pyrogenes Sejroe Pyrogenes
Acute reciprocal titer 0 0 0 400
Convalescent reciprocal titer 200 800 12,800 NA
CT = cycle threshold; L. borgpetersenii = Leptospira borgpetersenii; L. kirschneri = Leptospira kirschneri; MAT = microscopic agglutination testing; NA = not available; ND = not detected.
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species-level identification of pathogenic Leptospira associ-
ated with human disease and provides robust evidence that
multiple Leptospira types are contributing to human lepto-
spirosis in Tanzania.
Phylogenetic analysis of a partial fragment of the secY gene
enabled comparison with L. borgpetersenii and L. kirschneri
genotypes identified in local livestock species. Sequences of
the Leptospira secY gene obtained from our study partici-
pants showed a high degree of similarity to secY sequences
obtained previously from livestock in Tanzania. In particular,
L. borgpetersenii is commonly carried by cattle in northern
Tanzania,4 and the genotypederived fromapatient in our study
was highly similar to that of L. borgpetersenii sequences
obtained from cattle in Tanzania that were sampled during the
same time period and same geographic region.4 However, a
high degree of similarity was also seen in sequences from three
Leptospira reference serovars including L. borgpetersenii
serovar Balcanica, previously detected in cattle in Zimbabwe29;
L. borgpetersenii serovar Tunis, previously detected from pigs
in Tunisia30; and L. borgpetersenii serovar Tarassovi, which has
been detected among a wide variety of wildlife and livestock
from a broad geographical distribution.31–36 Likewise, the
L. kirschneri genotype derived from a human participant in our
study was similar to but distinct from sequences derived from
livestock in Tanzania.4 This finding suggests a less recent
common ancestor between the L. kirschneri genotypes de-
tected in our study and those previously detected in livestock
than for L. borgpetersenii genotypes.
Source attribution for Leptospira infection requires a thor-
ough characterization of local Leptospira serovars or se-
quence types as well as a good understanding of the animal
host range and potential transmission pathways for each of
these types.37,38 The relatively small amount of published
Leptospira sequence data from Tanzania, combined with the
limited amount of typing that can be performed for Leptospira
in the absence of cultured isolates, means that we are unable
to robustly infer the sources of infection for the febrile patients
enrolled in our study. However, based on our current
FIGURE 1. Phylogenetic tree showing the relationship between Leptospira secY gene (434-bp fragment) derived from human infections in
Tanzania with sequence from reference serovars8 and previously published sequences from human and animal infection in Tanzania4,27 The
phylogenetic treewas constructed using themaximum likelihoodmethod using the Tamura 3-parameter (T92) nucleotide substitutionmodel with a
discrete gamma distribution.44 The tree with the highest log likelihood is shown. Sequences from our study are labeled with unique identifiers
(FEVERXXXX) and GenBank accession numbers and highlighted in red. Sequences generated from reference Leptospira serovars and from other
studies in Tanzania are shown and labeled with GenBank accession numbers and ST types, respectively.45 Expanded clades show reference
serovarsmost closely related to the study genotypes. Clades of more distantly related species are collapsed and labeled with species names only.
Country locations and host are shown in parenthesis for East African studies. DRC = Democratic Republic of Congo; sv = serovar; ST = sequence
types. This figure appears in color at www.ajtmh.org.
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understanding of the epidemiology and biology of these
Leptospira species, we think that it is plausible that the three
differentLeptospira spp. detected in patients in our studyhave
distinct epidemiology and transmission pathways. First, the
three different Leptospira spp. detected in our study have
previously been identified in different animal hosts in Tanza-
nia. To date, L. borgpetersenii has only been detected in cattle
and rodents in Tanzania, whereas L. kirschneri appears to
have a broader animal host range including cattle, sheep,
goats, and rodents.4,27 In addition, other studies have dem-
onstrated biological differences between Leptospira species.
For example, L. borgpetersenii has reduced environmental
survival compared with L. interrogans, and hence, relies more
heavily on direct contact for host-to-host transmission.39
Therefore, we hypothesize that infection transmission may be
occurring under different environmental conditions for each of
the Leptospira species identified, with important implications
for public health strategies to reduce the burden of infection.
Overall, our study was limited by the small number of PCR-
positive samples from human participants available for anal-
ysis. Our PCR approach had relatively low sensitivity and
detected fewer than 4% of acute leptospirosis cases, despite
focusing our selection on acute blood and urine samples from
participants that met international guidelines serological case
definitions for acute leptospirosis.16 Testing the entire cohort
with both MAT and PCR is likely to have detected additional
cases as although MAT using paired serum is the reference
standard for serological diagnosis for leptospirosis, it has im-
perfect sensitivity as some patients will not seroconvert.17,40–42
Resource limitations preclude testing all participants with both
assays.
Many studies report that MAT testing of paired serum
samples detected cases that were unable to be detected by
PCR,17,40–42 but the proportion of serologically confirmed
cases who tested positive by PCR was surprisingly low in our
study. One possible explanation for the surprisingly low pro-
portion positive by PCRwas that at least half of participants in
our studies reported a fever for greater than 7 days before
sample collection. PCR has highest sensitivity during the
bacteremic phase of leptospirosis during first 5–7 days of
symptoms.43 The high reported prevalence of prior antimi-
crobial use may have further reduced the proportion positive
by culture and PCR in our studies by sterilizing blood before
enrollment preventing bacterial growth, or reducing lepto-
spiral load below the lower limit of detection for the real-time
PCR assay. In addition, we performed the PCR assays on
serum and plasma, which may have lower sensitivity than
whole blood.21 Despite this limitation, the small amount of
molecular data that we obtained has helped to expand our
understanding of the diversity of Leptospira present in north-
ern Tanzania and also provided some intriguing insights into
the relationship between infecting Leptospira species and
serogroup in patients with acute febrile illness. For example,
Sejroe was the predominant reactive serogroup in two pa-
tients who each were infected with different Leptospira spe-
cies: L. borgpetersenii and L. interrogans. This suggests that
molecular typing may reveal greater diversity than serology
alone. Furthermore, the use of Leptospira real-time PCR
allowed us to detect a fatal case of leptospirosis in our patient
cohort that may otherwise have been undetected and dem-
onstrates the potential value of PCR in understanding the
prevalence of fatal leptospirosis.
Our study has provided some new insights into the com-
plexity of Leptospira transmission pathways in Tanzania. Given
the relatively small amount of data and the high incidence of
human leptospirosis inTanzania,1,15we think that furtherwork is
needed to determine the diversity of Leptospira species and
genotypescontributing tobothhumanandanimal infection, and
to understand sources of infection and epidemiological trans-
mission sources for human leptospirosis. This could in turn in-
form efforts to control and prevent human disease.
Based on our findings, we recommend the combined use
of both serological and NAAT diagnostic approaches to
diagnose and investigate the epidemiology of human lepto-
spirosis. This is particularly important where delays in pre-
sentation tohealthcare facilities are common, orwhen there isa
high prevalence of prehospital antibacterial use. Additional ef-
forts to obtain Leptospira genetic material from human lepto-
spirosis cases are needed to help prioritize Leptospira species
and genotypes for control and critical insights into the links
between human and animal infection and help understand
transmission of this complex but important pathogen.
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